Abstract
Squamous cell carcinoma (SCC) is an invasive epithelial malignancy that arises from the prickle–squamous cell layers of the epidermis and shows keratinocytic differentiation. It is capable of metastasis to regional lymph nodes and is potentially lethal. SCC was first distinguished from basal cell carcinoma by Kompecher in 1902 [1]. The terms “squamous cell epithelioma,” “epidermoid carcinoma,” “epithelioma spinocellular,” “prickle cell epithelioma,” and “spinalioma” have all been used in the literature, but “squamous cell carcinoma” is the preferred terminology.
Keywords
Squamous Cell Carcinoma Sentinel Lymph Node Biopsy Basal Cell Carcinoma Invasive Squamous Cell Carcinoma Medial Canthus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Surv Ophthalmol. 1986;30(6):349–65.PubMedCrossRefGoogle Scholar
- 2.Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology. 2004;111(4):617–23.PubMedCrossRefGoogle Scholar
- 3.Cook Jr BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746–50.PubMedCrossRefGoogle Scholar
- 4.Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer. 1974;34(4):1333–8.PubMedCrossRefGoogle Scholar
- 5.Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol. 1992;1(1):47–51.PubMedCrossRefGoogle Scholar
- 6.Lim VS, Amrith S. Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008. Br J Ophthalmol. 2012;96(12):1462–5.PubMedCrossRefGoogle Scholar
- 7.Kwitko ML, Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis. Arch Ophthalmol. 1963;69:693–7.PubMedCrossRefGoogle Scholar
- 8.Aurora AL, Blodi FC. Lesions of the eyelids: a clinico- pathological study. Surv Ophthalmol. 1970;5:94–104.Google Scholar
- 9.Maclean H, Dhillon B, Ironside J. Squamous cell carcinoma of the eyelid and the acquired immunodeficiency syndrome. Am J Ophthalmol. 1996;121(2):219–21.PubMedGoogle Scholar
- 10.Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86(10):1161–5.PubMedCrossRefGoogle Scholar
- 11.Cook Jr BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088–98; quiz 99–100, 121.PubMedCrossRefGoogle Scholar
- 12.Malhotra R, James CL, Selva D, et al. The Australian Mohs database: periocular squamous intraepidermal carcinoma. Ophthalmology. 2004;111(10):1925–9.PubMedGoogle Scholar
- 13.Faustina M, Diba R, Ahmadi MA, Esmaeli B. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology. 2004;111(10):1930–2.PubMedCrossRefGoogle Scholar
- 14.McNab AA, Francis IC, Benger R, Crompton JL. Perineural spread of cutaneous squamous cell carcinoma via the orbit. Clinical features and outcome in 21 cases. Ophthalmology. 1997;104(9):1457–62.PubMedCrossRefGoogle Scholar
- 15.Bowyer JD, Sullivan TJ, Whitehead KJ, et al. The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstr Surg. 2003;19(4):275–81.PubMedCrossRefGoogle Scholar
- 16.Petsuksiri J, Frank SJ, Garden AS, et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer. 2008;112(1):111–8.PubMedCrossRefGoogle Scholar
- 17.Luxenberg MN, Guthrie Jr TH. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthalmology. 1986;93(4):504–10.PubMedGoogle Scholar
- 18.Couch SM, Custer PL. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy. Ophthal Plast Reconstr Surg. 2012;28(3):181–3.PubMedCrossRefGoogle Scholar
- 19.Ross AH, Kennedy CT, Collins C, Harrad RA. The use of imiquimod in the treatment of periocular tumours. Orbit. 2010;29(2):83–7.PubMedCrossRefGoogle Scholar
- 20.Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30(2 Pt 2):264–71.PubMedCrossRefGoogle Scholar
- 21.Rossi R, Puccioni M, Mavilia L, et al. Squamous cell carcinoma of the eyelid treated with photodynamic therapy. J Chemother. 2004;16(3):306–9.PubMedGoogle Scholar
- 22.Soysal HG, Markoc F. Invasive squamous cell carcinoma of the eyelids and periorbital region. Br J Ophthalmol. 2007;91(3):325–9.PubMedCrossRefGoogle Scholar
- 23.Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.PubMedCrossRefGoogle Scholar
- 24.Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1993;28(4):628–31.Google Scholar
- 25.Carcinoma of the eyelid. In: Edge SE, Byrd DR, Carducci MA, Compton CA, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
- 26.Crawford C, Fernelius C, Young P, et al. Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review. Clin Ophthalmol. 2011;5:1645–8.PubMedCrossRefGoogle Scholar
- 27.Howard GR, Nerad JA, Carter KD, Whitaker DC. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol. 1992;113(2):123–33.PubMedGoogle Scholar
- 28.Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542–7.PubMedCrossRefGoogle Scholar
- 29.Cottel WI. Perineural invasion by squamous-cell carcinoma. J Dermatol Surg Oncol. 1982;8(7):589–600.PubMedCrossRefGoogle Scholar
- 30.Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26(6):521–30.PubMedCrossRefGoogle Scholar
- 31.Loeffler M, Hornblass A. Characteristics and behavior of eyelid carcinoma (basal cell, squamous cell sebaceous gland, and malignant melanoma). Ophthalmic Surg. 1990;21(7):513–8.PubMedGoogle Scholar
- 32.Cribier B, Asch P, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology. 1999;199(3):208–12.PubMedCrossRefGoogle Scholar
- 33.Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg. 2004;30(2 Pt 2):326–33. discussion 33.PubMedCrossRefGoogle Scholar
- 34.Hutchinson J. Morbid growths and tumours. The ‘crateriform ulcer of the face’, a form of acute epithelial cancer. Trans Pathol Soc Lond. 1889;40:275–81.Google Scholar
- 35.Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Periocular keratoacanthoma: clinical features, pathology, and management. Ophthalmology. 2003;110(7):1403–7.PubMedCrossRefGoogle Scholar
- 36.Grossniklaus HE, Wojno TH, Yanoff M, Font RL. Invasive keratoacanthoma of the eyelid and ocular adnexa. Ophthalmology. 1996;103(6):937–41.PubMedCrossRefGoogle Scholar
- 37.Leibovitch I, Huilgol SC, James CL, et al. Periocular keratoacanthoma: can we always rely on the clinical diagnosis? Br J Ophthalmol. 2005;89(9):1201–4.PubMedCrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 2014